Olaris Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Series B1
- Latest Deal Amount
-
$15M
- Investors
-
10
Olaris General Information
Description
Developer of a precision diagnostics platform designed to identify biomarkers of treatment response. The company uses metabolite profiling and customized machine learning algorithms to determine therapy response and associated outcomes, enabling biopharmaceutical companies to improve treatment efficacy and reduce adverse events.
Contact Information
Website
www.myolaris.comCorporate Office
- 175 Crossing Boulevard
- Suite 410
- Framingham, MA 01702
- United States
Corporate Office
- 175 Crossing Boulevard
- Suite 410
- Framingham, MA 01702
- United States
Olaris Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series B1) | 11-Apr-2025 | $15M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series B) | 21-Sep-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 01-Sep-2019 | Completed | Generating Revenue | |||
| 4. Seed Round | 01-Jan-2019 | Completed | Generating Revenue | |||
| 3. Grant | 23-Jul-2018 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Olaris Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B1 | ||||||||
| Series B | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 1,246,622 | $0.000100 | $0.09 | $1.54 | $1.54 | 1x | $1.54 | 6.61% |
| Series A-1 | 2,175,146 | $0.000100 | $0.12 | $1.93 | $1.93 | 1x | $1.93 | 11.53% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Olaris Patents
Olaris Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4695602-A1 | Methods of detecting over-immunosuppression and under- immunosuppression in renal transplant recipients | Pending | 20-Oct-2023 | ||
| WO-2025085668-A1 | Methods of detecting over-immunosuppression and under- immunosuppression in renal transplant recipients | Inactive | 20-Oct-2023 | ||
| WO-2025085668-A9 | Methods of detecting over-immunosuppression and under- immunosuppression in renal transplant recipients | Inactive | 20-Oct-2023 | ||
| EP-4288774-A1 | Device, method and system for monitoring immune system response | Pending | 01-Mar-2021 | ||
| EP-4288774-A4 | Device, method and system for monitoring immune system response | Pending | 01-Mar-2021 | G01N33/5008 |
Olaris Signals
Olaris Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Labcorp Venture Fund | Corporate Venture Capital | Minority | ||
| Northpoint Capital Group | PE/Buyout | Minority | ||
| Angel (individual) | Minority | |||
| U.S. Boston Growth Capital | Growth/Expansion | Minority | ||
| Next Act Fund | Angel Group | Minority |
Olaris FAQs
-
When was Olaris founded?
Olaris was founded in 2014.
-
Where is Olaris headquartered?
Olaris is headquartered in Framingham, MA.
-
What is the size of Olaris?
Olaris has 17 total employees.
-
What industry is Olaris in?
Olaris’s primary industry is Discovery Tools (Healthcare).
-
Is Olaris a private or public company?
Olaris is a Private company.
-
What is the current valuation of Olaris?
The current valuation of Olaris is .
-
What is Olaris’s current revenue?
The current revenue for Olaris is .
-
How much funding has Olaris raised over time?
Olaris has raised $29M.
-
Who are Olaris’s investors?
Labcorp Venture Fund, Northpoint Capital Group, , U.S. Boston Growth Capital, and Next Act Fund are 5 of 10 investors who have invested in Olaris.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process